Bumetanide Injection
Product Images NDC 67184-0593

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 67184-0593). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qilu Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Bumetanide Injection Usp 1)

Chemical structure of Bumetanide showing its aromatic ring with attached functional groups including carboxyl (COOH), sulfonamide (SO2NH2), ethylamine (CH3(CH2)3HN), and phenoxy (OC6H5).*

FDA Label Image

Principal Display Panel (4 mL Vial Label)

The label for Bumetanide Injection, USP, shows a strength of 1 mg/4 mL (0.25 mg/mL) in a 4 mL single dose vial for intravenous or intramuscular use. It contains benzyl alcohol and is manufactured by Qilu Pharmaceutical (Hainan) Co., Ltd. The label includes storage instructions and notes that the container closure is not made with natural rubber latex.*

FDA Label Image

Principal Display Panel (4 mL Vial Carton)

Bumetanide Injection, USP 1 mg/4 mL (0.25 mg/mL) vial label for intravenous or intramuscular use. The label indicates 10 x 4 mL single dose vials, manufactured by Qilu Pharmaceutical Co., Ltd. The packaging includes dosing, storage, and ingredient information along with a barcode and lot details.*

FDA Label Image

Principal Display Panel (10 mL Vial Label)

Label for Bumetanide Injection, USP, 2.5 mg/10 mL (0.25 mg/mL) multiple dose vial. The injection is for intravenous or intramuscular use and contains benzyl alcohol. Manufactured by Qilu Pharmaceutical (Hainan) Co., Ltd., Haikou, China. The label includes storage instructions, lot, and expiration placeholders, and states the container closure is not made with natural rubber latex.*

FDA Label Image

Principal Display Panel (10 mL Vial Carton)

Bumetanide Injection, USP 2.5 mg/10 mL (0.25 mg/mL) injection label for intravenous or intramuscular use. The label indicates 10 x 10 mL multiple dose vials. Manufactured by Qilu Pharmaceutical Co., Ltd. The label features dosage, storage instructions, and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.